Estrogen receptor alpha XbaI polymorphism is associated with higher relaxin-3 levels in women with metabolic syndrome
Records of Pharmaceutical and Biomedical Sciences · 2018
DOI: 10.21608/rpbs.2018.5916 ↗Kurz gefasst
Fachartikel in der Zeitschrift Records of Pharmaceutical and Biomedical Sciences, 2018. Verfasst von Eman Mehanna und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mehanna, E., Mesbah, N., Ghattas, M., & Abo-Elmatty, D. (2018). Estrogen receptor alpha XbaI polymorphism is associated with higher relaxin-3 levels in women with metabolic syndrome. Records of Pharmaceutical and Biomedical Sciences. https://doi.org/10.21608/rpbs.2018.5916
Vancouver
Mehanna E, Mesbah N, Ghattas M, Abo-Elmatty D. Estrogen receptor alpha XbaI polymorphism is associated with higher relaxin-3 levels in women with metabolic syndrome. Records of Pharmaceutical and Biomedical Sciences. 2018. doi:10.21608/rpbs.2018.5916
BibTeX
@article{Mehanna2018,
author = {Mehanna, Eman and Mesbah, Noha and Ghattas, Maivel and Abo-Elmatty, Dina},
title = {Estrogen receptor alpha XbaI polymorphism is associated with higher relaxin-3 levels in women with metabolic syndrome},
journal = {Records of Pharmaceutical and Biomedical Sciences},
year = {2018},
doi = {10.21608/rpbs.2018.5916}
}
EUVIMED